scispace - formally typeset
R

Raben Rosenberg

Researcher at Aarhus University Hospital

Publications -  86
Citations -  3700

Raben Rosenberg is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Panic disorder & Hyperintensity. The author has an hindex of 30, co-authored 85 publications receiving 3457 citations. Previous affiliations of Raben Rosenberg include Aarhus University & Copenhagen University Hospital.

Papers
More filters
Journal ArticleDOI

Depression, anxiety, health‐related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain

TL;DR: Chronic pain patients with FM and NP had significantly more mental distress including depression and anxiety than healthy controls both by self‐rating and by a professional rating, suggesting that different mechanisms are responsible for the development of mood disorders in the two patient groups.
Journal ArticleDOI

Cognitive deficits in major depression.

TL;DR: The present study of the cognitive functions in depression was part of an extensive investigation, including neuropsychological testing, psychiatric examination, and neuroimaging, confirming the current notion that depressed patients suffer from wide-spread cognitive impairments.
Journal ArticleDOI

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

TL;DR: Cannabis-induced psychotic disorders are of great clinical and prognostic importance, and development of schizophrenia-spectrum disorders was often delayed, and 47.1% of patients received a diagnosis more a year after seeking treatment for a cannabis-induced psychosis.
Journal ArticleDOI

Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo.

TL;DR: It is concluded that NOS inhibitors increased extracellular levels of 5‐HT and DA in the rat ventral hippocampus after local or systemic administration, whereas the NO precursor L‐Arg had the opposite effect.
Journal ArticleDOI

Local, but not systemic, administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.

TL;DR: It is found that citalopram, paroxetine, imipramine and N(G)-nitro-L-arginine dose dependently decreased the hippocampal NOS activity in vitro, in vivo and ex vivo, and this may reflect a secondary action of antidepressants on the glutamate NMDA receptor following their primary inhibitory action at the 5-HT transporter.